Article Fact Checked

Medically Reviewed

/ Updated April 8th, 2022

Why CAR T-Cell Therapy Is So Exciting

NOW
PLAYING
New Therapy Provides Hope for More Patients With Large B-Cell Lymphoma
NOW
PLAYING
One Patient’s Success Story Using Newly Approved CAR-T Cell Therapy to Treat Acute Lymphoblastic Leukemia in Adult Patients
NOW
PLAYING
The Remarkable Story of Pharma CEO Christi Shaw Who Took a Year Off to Care For Her Sister With Blood Cancer, and Then Helped Launch a Breakthrough CAR-T Cell Therapy
NOW
PLAYING
CAR T-Cell Therapy Side Effects Can Be Serious, But Many Are Short-Lived
NOW
PLAYING
CAR T-Cell Therapy: What It’s Like to Get This Groundbreaking New Cancer Treatment

Recurrence: Options After Diffuse Large B-Cell Lymphoma Recurrence

SEE MORE   

  • There are several treatment options available if non-Hodgkin lymphoma returns
  • The most common first treatment after relapse is another round of chemotherapy
  • For patients whose cancer does not respond well to chemo, doctors may explore immune-therapies such as CAR-T therapy

Recurrence: Options After Diffuse Large B-Cell Lymphoma Recurrence

  • There are several treatment options available if non-Hodgkin lymphoma returns
  • The most common first treatment after relapse is another round of chemotherapy
  • For patients whose cancer does not respond well to chemo, doctors may explore immune-therapies such as CAR-T therapy
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.